We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
-11.9%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.02B
AUM Growth
-$224M
(-18%)
Cap. Flow
-$66M
Cap. Flow
% of AUM
-6.44%
Top 10 Holdings %
Top 10 Hldgs %
37.29%
Holding
460
New
60
Increased
97
Reduced
133
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ERF
Enerplus Corporation
ERF
|
+$40.3M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$31.8M |
| 3 |
Ovintiv
OVV
|
+$27M |
| 4 |
Apple
AAPL
|
+$11.9M |
| 5 |
Cigna
CI
|
+$8.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$34.5M |
| 2 |
Antero Resources
AR
|
+$25.9M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$24M |
| 4 |
DEN
Denbury Inc.
DEN
|
+$14.9M |
| 5 |
HCA Healthcare
HCA
|
+$13.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 35.74% |
| 2 | Healthcare | 12.12% |
| 3 | Technology | 11.16% |
| 4 | Financials | 9.37% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
PJT Partners
PJT
$4.37B
| $1.07M | 0.1% |
+15,186
| New | +$1.06M |
|
152
Xenon Pharmaceuticals
XENE
$6.32B
| $1.06M | 0.1% |
+35,000
| New | +$1.06M |
|
153
Hercules Capital
HTGC
$2.94B
| $1.06M | 0.1% |
78,800
-8,463
| -10% | -$132K |
|
154
Krystal Biotech
KRYS
$9.88B
| $1.04M | 0.1% |
15,841
-2,890
| -15% | -$180K |
|
155
Ambarella
AMBA
$2.99B
| $1.03M | 0.1% |
15,677
-3,608
| -19% | -$291K |
|
|
SHCO
156
DELISTED
Soho House & Co
SHCO
| $1.01M | 0.1% |
155,484
-9,542
| -6% | -$72.7K |
|
157
McDonald's
MCD
$188B
| $1M | 0.1% |
4,061
-25
| -0.6% | -$6.16K |
|
158
Kornit Digital
KRNT
$706M
| $996K | 0.1% |
31,412
-12,071
| -28% | -$639K |
|
|
ACH
159
Accendra Health
ACH
$240M
| $986K | 0.1% |
+31,358
| New | +$1.14M |
|
160
iShares MSCI ACWI ETF
ACWI
$32.6B
| $952K | 0.09% |
11,353
-12,888
| -53% | -$1.17M |
|
161
Life Time Group Holdings
LTH
$9.42B
| $940K | 0.09% |
73,031
+51,906
| +246% | +$741K |
|
|
PRVB
162
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $940K | 0.09% |
235,000
| – | – |
|
163
Kura Sushi USA
KRUS
$537M
| $935K | 0.09% |
18,875
-11,508
| -38% | -$514K |
|
164
MaxLinear
MXL
$6.41B
| $925K | 0.09% |
27,227
-7,647
| -22% | -$320K |
|
165
dLocal
DLO
$4.26B
| $917K | 0.09% |
+34,924
| New | +$894K |
|
166
Arcos Dorados Holdings
ARCO
$1.73B
| $913K | 0.09% |
135,424
-549
| -0.4% | -$4.05K |
|
167
Blackstone Secured Lending
BXSL
$5.41B
| $900K | 0.09% |
38,085
+2,071
| +6% | +$53.7K |
|
|
NETC
168
DELISTED
Nabors Energy Transition Corp.
NETC
| $874K | 0.09% |
87,380
| – | – |
|
169
Viper Energy
VNOM
$8.81B
| $869K | 0.08% |
32,547
-29,075
| -47% | -$883K |
|
|
CFLT
170
DELISTED
Confluent
CFLT
| $867K | 0.08% |
37,313
+27,072
| +264% | +$729K |
|
171
Fidelity National Financial
FNF
$13.9B
| $854K | 0.08% |
24,041
-72
| -0.3% | -$2.81K |
|
172
AbCellera Biologics
ABCL
$1.62B
| $851K | 0.08% |
+79,867
| New | +$676K |
|
173
Texas Roadhouse
TXRH
$12.7B
| $849K | 0.08% |
11,606
+2,107
| +22% | +$166K |
|
174
Saratoga Investment
SAR
$309M
| $844K | 0.08% |
35,221
+3,669
| +12% | +$95.1K |
|
175
Workiva
WK
$2.94B
| $834K | 0.08% |
12,645
-27,568
| -69% | -$2.29M |
|
Similar funds
VFG
SLG
KCP
UAG
PS
CICI
RPAM
BBI
Advisory Research's Q2 2022 Portfolio in Review
As of Q2 2022, Advisory Research held 460 positions worth $1.02B, down 18% from $1.25B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Advisory Research withdrew a net $66M in Q2 2022, closing 90 positions and reducing 133 holdings. Its most notable exit was Coterra Energy, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Energy at 36% of assets, up from 34% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Advisory Research opened a new position in Enerplus Corporation worth $38.7M.
- Advisory Research's largest Q2 2022 buy was Enerplus Corporation: 2,926,378 shares worth $38.7M.
- Advisory Research added most to Ovintiv in Q2 2022, an estimated $27M increase.
- Advisory Research's biggest Q2 2022 reduction was Devon Energy, cutting an estimated $34.5M.
- Advisory Research fully exited Coterra Energy in Q2 2022, selling an estimated $24M.
- Advisory Research's ten largest holdings make up 37% of its $1.02B portfolio in Q2 2022.
- Advisory Research opened 60 new positions and closed 90 in Q2 2022.
- Advisory Research's portfolio value fell 18% quarter-over-quarter to $1.02B.
Based on Advisory Research's 13F filing for Q2 2022, filed 15 Aug 2022.